Related Experiment Video
Updated: Jun 19, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest
Eliska Vaclavikova1, Sarka Dvorakova, Vlasta Sykorova
1Department of Molecular Endocrinology, Institute of Endocrinology, Narodni 8, 116 94, Prague 1, Czech Republic. evaclavikova@endo.cz
Abstract:
Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR). The aim of this study was to evaluate genotype-phenotype correlations of the frequently discussed Tyr791Phe mutation in exon 13 of the RET proto-oncogene. Screening of three groups of patients was performed (276 families with medullary thyroid carcinoma (MTC), 122 families with HSCR, and 29 patients with pheochromocytoma). We found this mutation in 3 families with apparently sporadic MTC, 3 families with FMTC/MEN2, 1 patient with pheochromocytoma, and 3 families with HSCR. All gene mutation carriers have a silent polymorphism Leu769Leu in exon 13. In three families second germline mutations were detected: Cys620Phe (exon 10) in MEN2A family, Met918Thr (exon 16) in MEN2B family, and Ser649Leu (exon 11) in HSCR patient. Detection of the Tyr791Phe mutation in MEN2/MTC and also in HSCR families leads to the question whether this mutation has a dual character (gain-of-function as well as loss-of-function). A rare case of malignant pheochromocytoma in a patient with the Tyr791Phe mutation is presented. This study shows various clinical characteristics of the frequently discussed Tyr791Phe mutation.
Insights
The RET proto-oncogene Tyr791Phe mutation shows varied clinical effects, appearing in both gain-of-function (medullary thyroid carcinoma) and loss-of-function (Hirschsprung
Area of Science:
- Genetics
- Oncology
- Endocrinology
Background:
- Activating RET proto-oncogene mutations are linked to familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A/2B.
- Inactivating RET mutations are associated with Hirschsprung's disease (HSCR).
- The Tyr791Phe mutation in RET exon 13 is frequently discussed for its role in these conditions.
Observation:
- Screening of 276 FMTC/MTC, 122 HSCR, and 29 pheochromocytoma families identified the Tyr791Phe mutation in sporadic MTC, FMTC/MEN2, pheochromocytoma, and HSCR.
- All Tyr791Phe carriers also possessed the Leu769Leu polymorphism in exon 13.
- Second germline mutations (Cys620Phe, Met918Thr, Ser649Leu) were found in three families.
Findings:
- The Tyr791Phe mutation was detected in patients with medullary thyroid carcinoma (MTC), multiple endocrine neoplasia (MEN) types 2A/2B, pheochromocytoma, and Hirschsprung's disease (HSCR).
- This suggests the Tyr791Phe mutation may possess dual gain-of-function and loss-of-function characteristics.
- A rare malignant pheochromocytoma case associated with Tyr791Phe is presented.
Implications:
- The study highlights the diverse clinical manifestations associated with the RET Tyr791Phe mutation.
- Understanding these genotype-phenotype correlations is crucial for accurate diagnosis and genetic counseling.
- Further research is needed to fully elucidate the dual functional capacity of this RET mutation.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
Mutations
Determination